Company intelligence
Inotiv
About Inotiv
WHERE INSIGHTS LEAD TO ANSWERS Expect More In choosing a partner for discovery, development and research models, expect more: more attention, more insight, and a superlative experience. You’ve worked hard to get this far, and you deserve a provider seamlessly aligned to your needs and goals. Through scientific leadership and ongoing investments, Inotiv delivers a comprehensive range of services and products that will exceed your expectations. Benefit from our long and impeccable regulatory history, world class team of scientists, and track record of providing attentive, decisive service. Answering the right questions on time and with high-quality data is the key to achieving your objectives. At Inotiv, that is our focus: to provide you with both the broad scope and right-size solutions essential to your success. Gain the insights you deserve to get the answers you need. Expect more — with Inotiv. Inotiv is a Top Workplaces 2023 Winner.
Verified activity
Signals from Inotiv
8 published signals
Research & Knowledge
Inotiv published comparative studies confirming that its Sentinel-Free Filter Testing (SiFT) aligns with the 3Rs and delivers greater pathogen detection sensitivity than traditional soiled bedding sentinels.
Reported by Inotiv
Presence & Recognition
Inotiv participated in the International Conference on Environmental Mutagens 2026 in Edinburgh.
Reported by Diane Brecha
Presence & Recognition
Inotiv is exhibiting at the EUROTOX 2026 conference at booth #2 to showcase its complete solution including models, surgical services, discovery, and safety assessment testing.
Reported by Inotiv
Presence & Recognition
Inotiv is looking forward to meeting European customers at Eurotox in a few weeks.
Reported by Diane Brecha
Research & Knowledge
Inotiv released an updated collection of research references for atherogenic and DIO diets.
Reported by Inotiv
Products & Services
Inotiv launched the Sentinel Free Filter Testing (SiFT) program, a smarter, more ethical soiled bedding testing solution that works alongside traditional methods.
Reported by Inotiv
Presence & Recognition
Inotiv held an on-demand webinar with Drug Discovery News featuring Dr. Crystal West and Dr. Joshua Justice demonstrating how Inotiv's DIO model can be leveraged alongside integrated proteomics, pathology, and metabolic assessment services to characterize obesity-driven changes across skeletal muscle and other tissues.
Reported by Inotiv
Research & Knowledge
Inotiv continues with in-depth characterization of preclinical models to help with selecting an appropriate model and providing confidence for endpoints in studies.
Reported by James Norman